ZA939477B - Insulin analogs - Google Patents

Insulin analogs

Info

Publication number
ZA939477B
ZA939477B ZA939477A ZA939477A ZA939477B ZA 939477 B ZA939477 B ZA 939477B ZA 939477 A ZA939477 A ZA 939477A ZA 939477 A ZA939477 A ZA 939477A ZA 939477 B ZA939477 B ZA 939477B
Authority
ZA
South Africa
Prior art keywords
insulin analogs
insulin
analogs
Prior art date
Application number
ZA939477A
Other languages
English (en)
Inventor
Ronald Eugene Chance Li Fan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA939477B publication Critical patent/ZA939477B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA939477A 1992-12-18 1993-12-17 Insulin analogs ZA939477B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99565992A 1992-12-18 1992-12-18

Publications (1)

Publication Number Publication Date
ZA939477B true ZA939477B (en) 1995-06-19

Family

ID=25542078

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939477A ZA939477B (en) 1992-12-18 1993-12-17 Insulin analogs

Country Status (14)

Country Link
EP (1) EP0605983A3 (cs)
JP (1) JPH08504820A (cs)
CN (1) CN1094059A (cs)
AU (1) AU680462B2 (cs)
BR (1) BR9307687A (cs)
CA (1) CA2151134A1 (cs)
CZ (1) CZ158895A3 (cs)
FI (1) FI953001A (cs)
HU (1) HUT71583A (cs)
MX (1) MX9307991A (cs)
NO (1) NO952336D0 (cs)
PL (1) PL310007A1 (cs)
WO (1) WO1994014461A1 (cs)
ZA (1) ZA939477B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
AU2009305472B2 (en) 2008-10-17 2013-12-19 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1 agonist
DK2498801T3 (en) 2009-11-13 2018-05-07 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION INCLUDING desPro36Exendin-4 (1-39) -Lys6-NH2 AND METHIONIN
EP2554183B1 (de) 2009-11-13 2018-04-04 Sanofi-Aventis Deutschland GmbH Pharmazeutische Zusammensetzung umfassend einen GLP-1-Agonisten, ein Insulin und Methionin
KR101823320B1 (ko) 2010-08-30 2018-01-31 사노피-아벤티스 도이칠란트 게엠베하 제２형 진성 당뇨병 치료용 약제를 제조하기 위한 ａｖｅ００１０의 용도
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP3395358B1 (en) * 2012-09-26 2019-11-06 Indiana University Research and Technology Corporation Insulin analog dimers
KR102578030B1 (ko) 2014-12-12 2023-09-14 사노피-아벤티스 도이칠란트 게엠베하 인슐린 글라진／릭시세나티드 고정비 제형
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
NO922376L (no) * 1991-06-21 1992-12-22 Lilly Co Eli Insulinanaloger

Also Published As

Publication number Publication date
EP0605983A3 (en) 1995-06-07
EP0605983A2 (en) 1994-07-13
NO952336L (no) 1995-06-13
WO1994014461A1 (en) 1994-07-07
AU680462B2 (en) 1997-07-31
FI953001A0 (fi) 1995-06-16
HU9501762D0 (en) 1995-08-28
BR9307687A (pt) 2002-02-19
NO952336D0 (no) 1995-06-13
CZ158895A3 (en) 1995-12-13
PL310007A1 (en) 1995-11-13
MX9307991A (es) 1994-08-31
JPH08504820A (ja) 1996-05-28
FI953001A (fi) 1995-06-16
CN1094059A (zh) 1994-10-26
HUT71583A (en) 1995-12-28
AU5827994A (en) 1994-07-19
CA2151134A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
ZA939317B (en) Medicament
ZA939477B (en) Insulin analogs
GB2271934B (en) Syringe
HK1000347A1 (en) Syringe
IL102240A0 (en) Insulin analogs
GB9016375D0 (en) Syringe
GB9219302D0 (en) Improvements relating to syringe
GB9205505D0 (en) Cyclic compounds
ZA90838B (en) Insulin analogs
HU9402245D0 (en) Syringe
GB9215876D0 (en) Syringe
ZA935302B (en) Syringe
PL304717A1 (en) Syringe
GB9224973D0 (en) Syringe
GB9219443D0 (en) Syringes
GB9101479D0 (en) Improved syringe
IL120356A0 (en) Hydantocidin analogs
CA66344S (en) Syringe
CA66409S (en) Syringe
CA65932S (en) Syringe
GB9117800D0 (en) Syringe
GB9108155D0 (en) Syringe
GB9108154D0 (en) Syringe
IL101141A0 (en) Syringe
PL291516A1 (en) Syringe